US Stock MarketDetailed Quotes
APLT Applied Therapeutics
- 8.570
- -1.640-16.06%
Close Nov 27 16:00 ET
- 1.870
- -6.700-78.18%
Post 18:40 ET
997.17MMarket Cap-6035P/E (TTM)
10.400High8.390Low14.51MVolume10.250Open10.210Pre Close134.09MTurnover17.17%Turnover RatioLossP/E (Static)116.36MShares10.62452wk High168.04P/B724.07MFloat Cap1.85052wk Low--Dividend TTM84.49MShs Float57.390Historical High--Div YieldTTM19.69%Amplitude0.500Historical Low9.241Avg Price1Lot Size
Applied Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 122K | 144K | -98.22%190K | 9.99M | -667K | 0 | 0 | 10.66M | 0 | 0 |
| Operating revenue | --122K | --144K | -98.22%190K | --9.99M | ---667K | --0 | --0 | --10.66M | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 92.74%29.87M | 19.84%20.58M | -1.09%21.28M | -10.15%74.53M | 7.22%20.34M | -19.95%15.5M | -20.19%17.18M | -6.85%21.52M | -21.46%82.95M | -30.03%18.97M |
| Selling and administrative expenses | 219.26%15.04M | 99.89%10.58M | 62.39%9.07M | -24.50%20.62M | -26.77%5.04M | -24.52%4.71M | -13.58%5.29M | -30.83%5.58M | -36.55%27.32M | -39.60%6.88M |
| -General and administrative expense | 219.26%15.04M | 99.89%10.58M | 62.39%9.07M | -24.50%20.62M | -26.77%5.04M | -24.52%4.71M | -13.58%5.29M | -30.83%5.58M | -36.55%27.32M | -39.60%6.88M |
| Research and development costs | 37.49%14.83M | -15.81%10M | -23.33%12.22M | -3.11%53.91M | 26.55%15.3M | -17.77%10.79M | -22.82%11.88M | 6.02%15.94M | -11.09%55.63M | -23.10%12.09M |
| Operating profit | -91.95%-29.74M | -19.00%-20.44M | -94.26%-21.09M | 22.20%-64.54M | -10.73%-21.01M | 19.95%-15.5M | 20.19%-17.18M | 53.00%-10.86M | 21.46%-82.95M | 30.03%-18.97M |
| Net non-operating interest income expense | 246.17%1.36M | 53.92%628K | 165.16%586K | 100.29%1.37M | 29.89%352K | 72.69%392K | 267.57%408K | 190.79%221K | 23.42%685K | 15.81%271K |
| Non-operating interest income | 246.17%1.36M | 53.92%628K | 165.16%586K | 100.29%1.37M | 29.89%352K | 72.69%392K | 267.57%408K | 190.79%221K | --685K | --271K |
| Other net income (expense) | -47.45%-40.21M | 277.30%22.71M | -12,786.20%-63.43M | -23,192.18%-56.6M | -498.48%-17.02M | -97,482.14%-27.27M | -188.04%-12.81M | 620.83%500K | 53.36%-243K | 1,631.18%4.27M |
| Gain on sale of security | -47.32%-40.18M | 277.63%22.74M | -13,619.19%-63.41M | -85,616.67%-56.57M | -498.64%-16.96M | -75,869.44%-27.28M | -193.87%-12.8M | --469K | ---66K | --4.26M |
| Other non- operating income (expenses) | -310.00%-21K | -580.00%-34K | -183.87%-26K | 84.75%-27K | -458.82%-61K | 225.00%10K | 94.44%-5K | 132.29%31K | 66.03%-177K | 106.09%17K |
| Income before tax | -61.89%-68.59M | 109.80%2.9M | -728.04%-83.94M | -45.15%-119.76M | -161.13%-37.68M | -121.82%-42.37M | -14.39%-29.58M | 56.16%-10.14M | 21.86%-82.51M | 46.87%-14.43M |
| Income tax | ||||||||||
| Net income | -61.89%-68.59M | 109.80%2.9M | -728.04%-83.94M | -45.15%-119.76M | -161.13%-37.68M | -121.82%-42.37M | -14.39%-29.58M | 56.16%-10.14M | 21.86%-82.51M | 46.87%-14.43M |
| Net income continuous Operations | -61.89%-68.59M | 109.80%2.9M | -728.04%-83.94M | -45.15%-119.76M | -161.13%-37.68M | -121.82%-42.37M | -14.39%-29.58M | 56.16%-10.14M | 21.86%-82.51M | 46.87%-14.43M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -61.89%-68.59M | 109.80%2.9M | -728.04%-83.94M | -45.15%-119.76M | -161.13%-37.68M | -121.82%-42.37M | -14.39%-29.58M | 56.16%-10.14M | 21.86%-82.51M | 46.87%-14.43M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | -61.89%-68.59M | 109.80%2.9M | -728.04%-83.94M | -45.15%-119.76M | -161.13%-37.68M | -121.82%-42.37M | -14.39%-29.58M | 56.16%-10.14M | 21.86%-82.51M | 46.87%-14.43M |
| Basic earnings per share | -2.13%-0.48 | 105.41%0.02 | -272.22%-0.67 | 34.86%-1.42 | -106.25%-0.33 | -17.50%-0.47 | 61.46%-0.37 | 79.55%-0.18 | 47.09%-2.18 | 84.62%-0.16 |
| Diluted earnings per share | -2.13%-0.48 | 64.86%-0.13 | -272.22%-0.67 | 34.86%-1.42 | -106.25%-0.33 | -17.50%-0.47 | 61.46%-0.37 | 79.55%-0.18 | 47.09%-2.18 | 84.62%-0.16 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data